The efficacy and safety of salmeterol compared to theophylline: Meta-analysis of nine controlled studies

Respiratory Medicine

Volumn 92, Issue 2, 1998, Pages 256-263

  Davies, B ^a   Brooks, G ^b   Devoy, M ^c  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MUSCLE CRAMP; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TACHYCARDIA; TIME; TREMOR;

EID: 0031881261     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90105-6     Document Type: Article

References (25)

1. Brogden RN, Faulds D. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airway disease. Drugs 1991; 42: 895-912.
2. 2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43: 674-678.
3. Britton MG, Earnshaw JS, Palmer JBD. A twelve month comparison of salmeterol and salbutamol in asthmatic patients. Eur Respir J 1992; 5: 1062-1067.
4. Lundbach B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993; 48: 148-153.
5. 2-agonist. Eur Respir Rev 1993; 3: 391-395.
6. McFadden ER. Methylxanthines in the treatment of asthma: the rise, the fall, and the possible rise again. Ann Intern Med 1991; 115: 323-324.
7. Persson CGA. Xanthines as airway anti-inflammatory drugs. J Allergy Clin Immunol 1988; 81: 615-617.
8. Johnston IDA. Theophylline in the management of airflow obstruction. Difficult drugs to use, few clinical indications. Br Med J 1990; 300: 929-931.
9. Nasser SSM, Rees PH. Theophylline. Current thoughts on the risks and benefits of its use in asthma. Drug Safety 1993; 8: 12-18.
10. Sacks HS, Berrier J, Reitman D et al. Meta-analysis of randomized controlled trials. N Engl J Med 1987; 316: 450-455.
11. Thacker SB. Meta-analysis: a quantitative approach to research integration. J Am Med Assoc 1988; 259: 1685-1689.
12. Davies BH, Tibbetts HA, Brooks GM et al. The efficacy and safety of salmeterol compared to theophylline: a meta-analytic integration of nine controlled studies. Eur Respir J 1995; 8 (Suppl. 19): 262.
13. Paggiaro PL, Giannini D, Di Franco A et al. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. Eur Respir J 1996; 9: 1689-1695.
14. Davies BH, Lyons H. Salmeterol xinafoate: a comparison with sustained-release theophylline in adult asthmatic patients. Am Rev Respir Dis 1992; 145: 737.
15. Fjellbirkeland L, Gulsvik A, Palmer JBD. The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease. Respir Med 1994; 88: 599-607.
16. Muir JF, Bertin L, Georges D, on behalf of a French Multicentre Study Group. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. Eur Respir J 1992; 5: 1197-1200.
17. Arossa W, Clini V, Fasolo A et al. Inhaled salmeterol and oral theophylline in patients with mild-to-moderate asthma: a multicentre clinical comparison. Abstract presented at Congress of Societa Italiana di Medicinia Respiratoria, July 1995.
18. D'Amato G, Ruggeri S, Ravinetto R et al. Inhaled salmeterol and oral theophylline in patients with moderate to severe asthma: a multicentre clinical comparison. Abstract presented at Congress of Societa Italiana di Medicinia Respiratoria, July 1995.
19. 2-agonist with prolonged duration of action. Lung 1993; 171: 249-264.
20. Paggiaro PL. Salmeterol and sustained release theophylline: a comparison in asthmatic patients. Eur J Clin Immunol 1992; 47: 348.
21. Vaitkiene N, Kvedariene V, Blaakziene A. The efficacy of inhaled salmeterol and individually oral dose of theophylline in the treatment of patients with moderate asthma. Eur Respir J 1996; 9 (Suppl. 23): 51S.
22. Howard TC. Audit of serum theophylline concentrations in patients from general practice. J Royal Coll Gen Pract 1987; 37: 105-106.
23. Neville RG. Clinical audit of theophylline use in general practice. Br J Clin Pract 1991; 45: 18-20.
24. Brown DW. Serum theophylline concentrations in general practice patients. J Royal Coll Gen Pract 1987; 37: 273-274.
25. Wiffen JK, Jackson SH. Prescribing habits for theophylline preparations. J Royal Soc Med 1983; 76: 917-919.